Cargando…

Expression of cancer cell-intrinsic PD-1 associates with PD-L1 and p-S6 and predicts a good prognosis in nasopharyngeal carcinoma

Aims: Programmed cell death ligand 1 (PD-L1) is the ligand of programmed death 1 (PD-1), which is a host immunity inhibitory receptor. Expression of PD-L1 in diverse tumor types has been widely discussed, while there is little research about tumor intrinsic-PD-1. Phospho-S6 (p-S6) is an important do...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yuting, Chen, Xianyong, Zheng, Hongmei, Zhan, Yuting, Luo, Jiadi, Yang, Yang, Ning, Yue, Wang, Haihua, Wang, Weiyuan, Fan, Songqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425204/ https://www.ncbi.nlm.nih.gov/pubmed/34539884 http://dx.doi.org/10.7150/jca.60739

Ejemplares similares

YB1 associates with oncogenetic roles and poor prognosis in nasopharyngeal carcinoma
por: Zhan, Yuting, et al.
Publicado: (2022)

Role of β-catenin in PD-L1 expression of nasopharyngeal carcinoma
por: Wang, Haihua, et al.
Publicado: (2023)

Clinical implications of the interaction between PD-1/PD-L1 and PI3K/AKT/mTOR pathway in progression and treatment of non-small cell lung cancer
por: Quan, Zihan, et al.
Publicado: (2022)

New insights into the important roles of tumor cell-intrinsic PD-1
por: Zheng, Hongmei, et al.
Publicado: (2021)

Targeting ALDH1A1 to induce Necroptosis in Nasopharyngeal Carcinoma
por: Wang, Haihua, et al.
Publicado: (2022)

Increased expression of heat shock protein (HSP) 10 and HSP70 correlates with poor prognosis of nasopharyngeal carcinoma
por: Feng, Juan, et al.
Publicado: (2019)

Co-expression of PD-L1 and HIF-1α predicts poor prognosis in Patients with Non-small Cell Lung Cancer after surgery
por: Zheng, Hongmei, et al.
Publicado: (2021)

YAP1 synergize with YY1 transcriptional co-repress DUSP1 to induce osimertinib resistant by activating the EGFR/MAPK pathway and abrogating autophagy in non-small cell lung cancer
por: Ning, Yue, et al.
Publicado: (2023)

Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer
por: Wen, Qiuyuan, et al.
Publicado: (2019)

miR-4634 augments the anti-tumor effects of RAD001 and associates well with clinical prognosis of non-small cell lung cancer
por: Liu, Sile, et al.
Publicado: (2020)

Exosome-mediated miR-7-5p delivery enhances the anticancer effect of Everolimus via blocking MNK/eIF4E axis in non-small cell lung cancer
por: Liu, Sile, et al.
Publicado: (2022)

Aberrant Expression of β-Catenin Correlates with Infiltrating Immune Cells and Prognosis in NSCLC
por: Zheng, Hongmei, et al.
Publicado: (2021)

Overexpression of p-4EBP1 associates with p-eIF4E and predicts poor prognosis for non-small cell lung cancer patients with resection
por: Tang, Yaoxiang, et al.
Publicado: (2022)

Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients
por: Tang, Yaoxiang, et al.
Publicado: (2021)

Emerging roles of lncRNA in Nasopharyngeal Carcinoma and therapeutic opportunities
por: Wang, Haihua, et al.
Publicado: (2022)

Activation of Akt/mTOR Pathway Is Associated with Poor Prognosis of Nasopharyngeal Carcinoma
por: Wang, Weiyuan, et al.
Publicado: (2014)

Comprehensive analysis of the mechanism and treatment significance of Mucins in lung cancer
por: Ning, Yue, et al.
Publicado: (2020)

Multiple Mechanisms Involving in Radioresistance of Nasopharyngeal Carcinoma
por: Zhan, Yuting, et al.
Publicado: (2020)

Overexpression of P4HA1 associates with poor prognosis and promotes cell proliferation and metastasis of lung adenocarcinoma
por: Ning, Yue, et al.
Publicado: (2021)

Elevated expression of G3BP1 associates with YB1 and p‐AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection
por: Zheng, Hongmei, et al.
Publicado: (2019)

PD-L1 predicts poor prognosis for nasopharyngeal carcinoma irrespective of PD-1 and EBV-DNA load
por: Zhou, Yajuan, et al.
Publicado: (2017)

Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinoma
por: Tang, Yanyan, et al.
Publicado: (2017)

The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications
por: Zheng, Hongmei, et al.
Publicado: (2018)

MicroRNAs associated with therapy of non-small cell lung cancer
por: Lu, Junmi, et al.
Publicado: (2018)

Clinical observation of the efficacy of PD‐1/PD‐L1 inhibitors in the treatment of patients with advanced solid tumors
por: Wang, Miao, et al.
Publicado: (2021)

Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells
por: Zhao, Yunlong, et al.
Publicado: (2018)

Increased expression of Cks1 protein is associated with lymph node metastasis and poor prognosis in nasopharyngeal carcinoma
por: Xu, Lina, et al.
Publicado: (2017)

Phosphorylated Mnk1 and eIF4E Are Associated with Lymph Node Metastasis and Poor Prognosis of Nasopharyngeal Carcinoma
por: Zheng, Jun, et al.
Publicado: (2014)

Genomic and microbial factors affect the prognosis of anti-pd-1 immunotherapy in nasopharyngeal carcinoma
por: Xu, Liqin, et al.
Publicado: (2022)

The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
por: Huang, Zi-Lu, et al.
Publicado: (2019)

PD-1 and PD-L1 expression in 132 recurrent nasopharyngeal carcinoma: the correlation with anemia and outcomes
por: Zhou, Yajuan, et al.
Publicado: (2017)

The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment
por: Hudson, Katie, et al.
Publicado: (2020)

PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinoma
por: Ma, Ke, et al.
Publicado: (2017)

Cancer Cell-Intrinsic PD-1 and Implications in Combinatorial Immunotherapy
por: Yao, Han, et al.
Publicado: (2018)

4EGI-1 induces apoptosis and enhances radiotherapy sensitivity in nasopharyngeal carcinoma cells via DR5 induction on 4E-BP1 dephosphorylation
por: Wang, Weiyuan, et al.
Publicado: (2016)

PD-1 and PD-L1 co-expression predicts favorable prognosis in gastric cancer
por: Wu, Yanhua, et al.
Publicado: (2017)

Anti-PD-1/PD-L1 for nasopharyngeal carcinoma: a comprehensive analysis of registered trials on ClinicalTrials.gov
por: Dai, Zelei, et al.
Publicado: (2023)

Increased Expression of Flotillin-2 Protein as a Novel Biomarker for Lymph Node Metastasis in Nasopharyngeal Carcinoma
por: Wen, Qiuyuan, et al.
Publicado: (2014)

Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?
por: Chocarro de Erauso, Luisa, et al.
Publicado: (2020)

Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment
por: Laubach, Kyra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l79i8ha4vu428k664f8sa39ojn